Key result
Although plasma angiotensinogen was higher in obese patients (P<0.05), it was not different between groups after adjustment for blood pressure, suggesting it may be secondary to hypertension.
Why the study?
Are plasma angiotensinogen concentrations elevated in obese patients compared to nonobese patients?
Observational (n=63)
Are plasma angiotensinogen concentrations elevated in obese patients compared to nonobese patients?
p-value: p=<.05
Increased plasma angiotensinogen in obese patients appears to be secondary to hypertension or obesity rather than an independent primary driver, as differences disappear after adjusting for blood pressure.
No takes yet. Share an insight, caveat, or question.
Angiotensinogen elevation in obesity may be hypertension-driven rather than causal; leaves independent role open for prospective confirmation.
S Umemura (1997) conducted an observational in Obesity and hypertension (n=63). Obesity vs. Nonobese was evaluated on Plasma angiotensinogen concentrations (p-AGT) (p=<.05). Although plasma angiotensinogen was higher in obese patients (P<0.05), it was not different between groups after adjustment for blood pressure, suggesting it may be secondary to hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: